Skip to content

The Use of LSD-25 as a Diagnostic Aid in Doubtful Cases of Schizophrenia

G. Sedman, J. C. Kenna

The British Journal of Psychiatry January 1, 1965 DOI: 10.1192/bjp.111.470.96 via OpenAlex

Summary

AI-generated from the abstract

LSD-25 may exaggerate catatonic and hebephrenic features in people with schizophrenia and produce a caricature of the personality in normal subjects. The drug's primary psychological effect is an exacerbation of existing symptomatology, achieved by weakening central functions and defense systems. Some early investigators considered LSD-25 of limited value as a diagnostic aid in psychiatry.

Study at a glance

Characteristics Review Peer reviewed
Intervention LSD-25
Topics LSD
Keywords Schizophrenia object-oriented programming Exacerbation Psychiatry Childhood schizophrenia
Citations 14
Key finding LSD-25 exacerbates existing psychiatric symptoms by weakening central functions and defense systems, and tends to exaggerate catatonic and hebephrenic features in schizophrenics while producing a caricature of personality in normal subjects.

Abstract

In the course of studying the clinical effects of LSD-25 various workers have commented upon its possible use as an aid to psychiatric diagnosis. Stoll (1947) and Becker (1949) considered it to be of limited value in this respect. Condrau (1949) pointed out that it tended to exaggerate catatonic and hebephrenic features in schizophrenics and to produce a caricature of the personality in normal subjects; the latter point also being made by Anderson and Rawnsley (1954). Von Felsinger et al . (1956) considered the primary psychological effect of the drug to be an exacerbation of existing symptomatology, through a weakening of central functions and defence systems.

Explore topics

Comments

No comments yet.

Log in to comment